HydroMark 4010-02-15-T1Recalls & reported problems
Devicor Medical Products, Inc. · HydroMARK Breast Biopsy Site Marker- MICRO · Class 2 · Implant
All models of HydroMark (11)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00841911101468), received between Jul 10, 2018 and Jul 10, 2018 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Hypersensitivity/Allergic reaction1
- Patient Problem/Medical Problem1
- Reaction1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJul 10, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED BY THE DOCTOR, POST PROCEDURE, HYDROMARK WAS INSERTED INTO THE PATIENT WITHOUT COMPLICATIONS ON (B)(6) 2018. AFTER THE PROCEDURE THE PATIENT WAS DISCHARGED HOME ON THE SAME DAY. THE PATIENT IS KNOWN TO HAVE AN ALLERGY TO POLYETHYLENE GLYCOL (PEG). WHEN SHE GOT HOME SHE FELT TINGLING AT THE SITE OF THE HYDROMARK AND WAS AWARE SHE WAS HAVING AN ALLERGIC REACTION. SHE SELF-ADMINISTERED HER EPIPEN. THE SYMPTOMS DID NOT DIMINISH SO SHE SELF-ADMINISTERED A 2ND DOSE OF HER EPIPEN. SHE DID NOT ALERT THE HOSPITAL. SHORTLY AFTER BUT ON THE SAME DAY SHE ARRIVED AT THE HOSPITAL A AND E DEPARTMENT AND WAS TREATED AS ANAPHYLACTIC SHOCK FOR A SEVERE ALLERGIC REACTION. SHE STAYED IN ITU FOR 2 DAYS. SHE WAS THE TRANSFERRED TO THE WARD FOR 1 DAY. SHE WAS DISCHARGED ON FRIDAY (B)(6). PROCEDURE WAS COMPLETED WITH THE DEVICE. PATIENT COMPLICATION: MEDICAL/SURGICAL TREATMENT WAS REQUIRED TO RESOLVE CONSEQUENCE. ADDITIONAL DETAILS: THE SURGICAL WASH USED PRIOR TO THE PROCEDURE WAS ECOLAB HYDREX PINK WHICH ALSO CONTAINS POLYETHYLENE GLYCOL.
Patient problems: Hypersensitivity/Allergic reaction; Patient Problem/Medical Problem; Reaction
MAUDE report 7674287 ↗
Other Marker, Radiographic, Implantable devices
- BioZorb F0202Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls192 reports
- BioZorb F0221Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE3 recalls15 reports
- BioZorb F0203Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls51 reports
- BioZorb F0231Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0303Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0304Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0404Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls6 reports
- BioZorb F0331Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page